Evaluation of a Closed-loop Insulin Delivery System at Home With Tailored Home Care Services in Poorly Controlled Type 2 Diabetes Patients (T2D) (CLOSEAP+)
Evaluation of a Closed-loop Insulin Delivery System at Home With Tailored Home Care Services in Poorly Controlled Type 2 Diabetes: a Randomized Controlled Trial vs Usual Care
Sponsor: Air Liquide Santé International
A NA clinical study on Diabetes Type 2, this trial is completed. The trial is conducted by Air Liquide Santé International and has accumulated 9 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
May 2025 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — May 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2023 — Jul 2024 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Sep 2022 — Sep 2023 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2022 — Sep 2022 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Dec 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Air Liquide Santé International
- International Clinical Trials Association
For direct contact, visit the study record on ClinicalTrials.gov .